IDIQ: chemistry, manufacturing and controls and related services for development of drug substances
Active Awarded Last action
- Contract number
- 75N95024D00009
- Awardee
-
Bachem Americas Inc. UEI ULM6JMNK5L83
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $127,700 obligated
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances Pre-Solicitation · 75N95023R00020 · Posted Apr 20, 2023
- Combined order value
- $127,700 Current and potential, with all options
- Last date to order 35% complete
- IDV ceiling <1% used
- $49,713,679.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 15 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Center for Advancing Translational Sciences (NCATS) awarded a single-award indefinite-delivery contract to Bachem Americas Inc. on May 15, 2024, with a ceiling value of $49,713,679 and an ultimate completion date of May 14, 2031. The contract covers Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug substances under Executive Order 14398.
Work is performed in Torrance, California. The originating solicitation, posted as a pre-solicitation on April 20, 2023 with a due date of May 5, 2023, sought CMC services to support pharmaceutical development programs, including process development, formulation studies, and current Good Manufacturing Practice (cGMP) manufacturing of active pharmaceutical ingredients.
The contract carries no set-aside designation. Recent task orders issued under this IDIQ include a $56,100 firm fixed-price delivery order from the National Institute on Drug Abuse (NIDA) for a three-year stability study extension on a cGMP batch of leucine enkephalin (L-ENK), with completion by September 28, 2028; a $45,200 firm fixed-price delivery order from NIDA for a three-year stability study extension on a cGMP batch of parathyroid hormone-related protein (PTH-IA), also completing by September 28, 2028; and a $26,400 firm fixed-price delivery order from NCATS for extended stability studies of PTH-IA, completing by March 31, 2027. All task orders are performed in Torrance, California and carry no set-aside designation.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00009?
75N95024D00009 was awarded to Bachem Americas Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 15, 2024.
How much is contract 75N95024D00009 worth?
Orders under 75N95024D00009 have obligated $127,700. 75N95024D00009's own ceiling is $49,713,679.
How many orders have been placed under contract 75N95024D00009?
3 orders have been placed under 75N95024D00009, the latest on September 29, 2025.
Who can order from contract 75N95024D00009?
75N95024D00009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95024D00009 part of a contract vehicle?
Yes. 75N95024D00009 is part of NCATS Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances.
Was contract 75N95024D00009 competed?
The extent of competition for 75N95024D00009 was full and open competition. The government received 15 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV